Global Information
회사소개 | 문의 | 비교리스트

사마귀 치료 시장 : 세계 산업 분석, 규모, 점유율, 성장률, 동향, 예측(2020-2030년)

Warts Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

리서치사 Transparency Market Research
발행일 2020년 06월 상품 코드 953602
페이지 정보 영문
가격
US $ 5,795 ₩ 6,494,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 인쇄는 가능하지만, 전체 페이지 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,795 ₩ 9,856,000 PDF (Multi-user License)
US $ 11,795 ₩ 13,218,000 PDF (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


사마귀 치료 시장 : 세계 산업 분석, 규모, 점유율, 성장률, 동향, 예측(2020-2030년) Warts Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030
발행일 : 2020년 06월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 사마귀 치료 시장을 조사했으며, 시장의 개요, 유형별, 사마귀 치료법별, 최종사용자별, 지역별 분석과 예측, 경쟁 구도, 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 서문

제2장 전제조건과 조사 방법

제3장 개요

제4장 시장 개요

  • 서론
    • 제품의 개요
  • 시장 역학
    • 성장 촉진요인
    • 성장 저해요인
    • 시장 기회

제5장 주요 조사 결과

  • 파이프라인 분석
  • COVID-19 영향 분석
  • 규제 시나리오

제6장 유형별 시장 분석과 예측

  • 주요 조사 결과/동향
  • 서론과 정의
  • 시장 가치 예측
    • 보통사마귀
    • 성기사마귀
    • 편평사마귀
    • 기타
  • 시장의 매력 분석

제7장 사마귀 치료법별 시장 분석과 예측

  • 주요 조사 결과/동향
  • 서론과 정의
  • 시장 가치 예측
    • 물리적 파괴
    • 화학적 파괴
    • 면역 조절
  • 시장의 매력 분석

제8장 최종사용자별 시장 분석과 예측,

  • 주요 조사 결과/동향
  • 서론과 정의
  • 시장 가치 예측
    • 병원
    • 진료소
    • 기타
  • 시장의 매력 분석

제9장 지역별 시장 분석과 예측,

  • 주요 지역
  • 시장 가치 예측
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동·아프리카
  • 시장의 매력 분석

제10장 북미

  • 시장 가치 예측
    • 미국
    • 캐나다

제11장 유럽

제12장 아시아태평양

제13장 라틴아메리카

제14장 중동·아프리카

제15장 경쟁 구도

  • 경쟁 매트릭스
    • Prestige Consumer Healthcare, Inc.
    • Bausch Health Companies, Inc.
  • 기업 개요(개요, 재무, 최신 동향, 전략)
    • Prestige Consumer Healthcare, Inc.
    • Bausch Health Companies, Inc.
    • Phio Pharmaceuticals Corp.
    • Verrica Pharmaceuticals
    • Teva Pharmaceuticals Industries Ltd.
    • Mylan NV
    • Scholl's Wellness Co.
    • Taro Pharmaceuticals Industries Ltd.
    • Cipla Ltd.
    • GlaxoSmithKline plc
    • Novan, Inc.
    • AIM ImmunoTech, Inc.
    • Merck & Co., Inc.
KSA 20.08.24

List of Tables

  • Table 01: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by Wart Type, 2018-2030
  • Table 02: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by Treatment Type, 2018-2030
  • Table 03: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by Physical Destruction, 2018-2030
  • Table 04: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by Freezing Cryotherapy, 2018-2030
  • Table 05: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by Chemical Destruction, 2018-2030
  • Table 06: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by Immunomodulation, 2018-2030
  • Table 07: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2018-2030
  • Table 08: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by Region, 2018-2030
  • Table 09: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by Country, 2018-2030
  • Table 10: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by Wart Type, 2018-2030
  • Table 11: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by Treatment Type, 2018-2030
  • Table 12: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by Physical Destruction, 2018-2030
  • Table 13: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by Freezing (Cryotherapy), 2018-2030
  • Table 14: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by Chemical Destruction, 2018-2030
  • Table 15: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by Immunomodulation, 2018-2030
  • Table 16: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2018-2030
  • Table 17: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 18: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by Wart Type, 2018-2030
  • Table 19: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by Type, 2018-2030
  • Table 20: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by Physical Destruction, 2018-2030
  • Table 21: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by Freezing (Cryotherapy), 2018-2030
  • Table 22: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by Chemical Destruction, 2018-2030
  • Table 23: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by Immunomodulation, 2018-2030
  • Table 24: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2018-2030
  • Table 25: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 26: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by Wart Type, 2018-2030
  • Table 27: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by Treatment Type, 2018-2030
  • Table 28: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by Physical Destruction, 2018-2030
  • Table 29: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by Freezing (Cryotherapy), 2018-2030
  • Table 30: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by Chemical Destruction, 2018-2030
  • Table 31: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by Immunomodulation, 2018-2030
  • Table 32: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2018-2030
  • Table 33: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 34: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by Wart Type, 2018-2030
  • Table 35: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by Type, 2018-2030
  • Table 36: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by Physical Destruction, 2018-2030
  • Table 37: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by Freezing (Cryotherapy), 2018-2030
  • Table 38: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by Chemical Destruction, 2018-2030
  • Table 39: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by Immunomodulation, 2018-2030
  • Table 40: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2018-2030
  • Table 41: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 42: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by Wart Type, 2018-2030
  • Table 43: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by Treatment Type, 2018-2030
  • Table 44: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by Physical Destruction, 2018-2030
  • Table 45: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by Freezing (Cryotherapy), 2018-2030
  • Table 46: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by Chemical Destruction, 2018-2030
  • Table 47: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by Immunomodulation, 2018-2030
  • Table 48: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2018-2030

List of Figure

  • Figure 01: Global Warts Therapeutics Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 02: Global Warts Therapeutics Market Value Share, by Wart Type, 2019
  • Figure 03: Global Warts Therapeutics Market Value Share, by Treatment Type, 2019
  • Figure 04: Global Warts Therapeutics Market Value Share, by End-user, 2019
  • Figure 05: Global Warts Therapeutics Market Value Share, by Region, 2019
  • Figure 06: Global Warts Therapeutics Market Value Share Analysis, by Wart Type, 2019 and 2030
  • Figure 07: Global Warts Therapeutics Market Attractiveness Analysis, by Wart Type, 2020-2030
  • Figure 08: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Common Warts, 2018-2030
  • Figure 09: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Genital Warts, 2018-2030
  • Figure 10: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Flat Warts, 2018-2030
  • Figure 11: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Others, 2018-2030
  • Figure 12: Global Warts Therapeutics Market Value Share Analysis, by Treatment Type, 2019 and 2030
  • Figure 13: Global Warts Therapeutics Market Attractiveness Analysis, by Treatment Type, 2020-2030
  • Figure 14: Global Warts Therapeutics Market Value Share Analysis, by Physical Destruction, 2019 and 2030
  • Figure 15: Global Warts Therapeutics Market Attractiveness Analysis, by Physical Destruction, 2020-2030
  • Figure 16: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Physical Destruction, 2018-2030
  • Figure 17: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Chemical Destruction, 2018-2030
  • Figure 18: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Immunomodulation, 2018-2030
  • Figure 19: Global Warts Therapeutics Market Value Share Analysis, by End-user, 2019 and 2030
  • Figure 20: Global Warts Therapeutics Market Attractiveness Analysis, by End-user, 2020-2030
  • Figure 21: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Hospitals, 2018-2030
  • Figure 22: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Clinics, 2018-2030
  • Figure 23: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Others, 2018-2030
  • Figure 24: Global Warts Therapeutics Market Value Share Analysis, by Region, 2019 and 2030
  • Figure 25: Global Warts Therapeutics Market Attractiveness Analysis, by Region, 2020-2030
  • Figure 26: North America Warts Therapeutics Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 27: North America Warts Therapeutics Market Value Share Analysis, by Country, 2019 and 2030
  • Figure 28: North America Warts Therapeutics Market Attractiveness Analysis, by Country, 2020-2030
  • Figure 29: North America Warts Therapeutics Market Value Share Analysis, by Wart Type, 2019 and 2030
  • Figure 30: North America Warts Therapeutics Market Attractiveness Analysis, by Wart Type, 2020-2030
  • Figure 31: North America Warts Therapeutics Market Value Share Analysis, by Treatment Type, 2019 and 2030
  • Figure 32: North America Warts Therapeutics Market Attractiveness Analysis, by Treatment Type, 2020-2030
  • Figure 33: North America Warts Therapeutics Market Value Share Analysis, by End-user, 2019 and 2030
  • Figure 34: North America Warts Therapeutics Market Attractiveness Analysis, by End-user, 2020-2030
  • Figure 35: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 36: Europe Warts Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 37: Europe Warts Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 38: Europe Warts Therapeutics Market Value Share Analysis, by Wart Type, 2019 and 2030
  • Figure 39: Europe Warts Therapeutics Market Attractiveness Analysis, by Wart Type, 2020-2030
  • Figure 40: Europe Warts Therapeutics Market Value Share Analysis, by Treatment Type, 2019 and 2030
  • Figure 41: Europe Warts Therapeutics Market Attractiveness Analysis, by Treatment Type, 2020-2030
  • Figure 42: Europe Warts Therapeutics Market Value Share Analysis, by End-user, 2019 and 2030
  • Figure 43: Europe Warts Therapeutics Market Attractiveness Analysis, by End-user, 2020-2030
  • Figure 44: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 45: Asia Pacific Warts Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 46: Asia Pacific Warts Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 47: Asia Pacific Warts Therapeutics Market Value Share Analysis, by Wart Type, 2019 and 2030
  • Figure 48: Asia Pacific Warts Therapeutics Market Attractiveness Analysis, by Wart Type, 2020-2030
  • Figure 49: Asia Pacific Warts Therapeutics Market Value Share Analysis, by Treatment Type, 2019 and 2030
  • Figure 50: Asia Pacific Warts Therapeutics Market Attractiveness Analysis, by Treatment Type, 2020-2030
  • Figure 51: Asia Pacific Warts Therapeutics Market Value Share Analysis, by End-user, 2019 and 2030
  • Figure 52: Asia Pacific Warts Therapeutics Market Attractiveness Analysis, by End-user, 2020-2030
  • Figure 53: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 54: Latin America Warts Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 55: Latin America Warts Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 56: Latin America Warts Therapeutics Market Value Share Analysis, by Wart Type, 2019 and 2030
  • Figure 57: Latin America Warts Therapeutics Market Attractiveness Analysis, by Wart Type, 2020-2030
  • Figure 58: Latin America Warts Therapeutics Market Value Share Analysis, by Treatment Type, 2019 and 2030
  • Figure 59: Latin America Warts Therapeutics Market Attractiveness Analysis, by Treatment Type, 2020-2030
  • Figure 60: Latin America Warts Therapeutics Market Value Share Analysis, by End-user, 2019 and 2030
  • Figure 61: Latin America Warts Therapeutics Market Attractiveness Analysis, by End-user, 2020-2030
  • Figure 62: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 63: Middle East & Africa Warts Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 64: Middle East & Africa Warts Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 65: Middle East & Africa Warts Therapeutics Market Value Share Analysis, by Wart Type, 2019 and 2030
  • Figure 66: Middle East & Africa Warts Therapeutics Market Attractiveness Analysis, by Wart Type, 2020-2030
  • Figure 67: Middle East & Africa Warts Therapeutics Market Value Share Analysis, by Treatment Type, 2019 and 2030
  • Figure 68: Middle East & Africa Warts Therapeutics Market Attractiveness Analysis, by Treatment Type, 2020-2030
  • Figure 69: Middle East & Africa Warts Therapeutics Market Value Share Analysis, by End-user, 2019 and 2030
  • Figure 70: Middle East & Africa Warts Therapeutics Market Attractiveness Analysis, by End-user, 2020-2030

Title:
Warts Therapeutics Market (Warts Type: Common Warts, Genital Warts, Flat Warts, and Others; Treatment Type: Physical Destruction, Chemical Destruction, and Immunomodulation; and Distribution Channel: Hospitals, Clinics, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030  .

Scope of the Report

TMR's report on the global warts therapeutics market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2020 to 2030. The report provides revenue of the global warts therapeutics market for the period 2018-2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global warts therapeutics market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global warts therapeutics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global warts therapeutics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global warts therapeutics market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global warts therapeutics market.

The report delves into the competition landscape of the global warts therapeutics market. Key players operating in the global warts therapeutics market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global warts therapeutics market that have been profiled in this report

Key Questions Answered:

  • What is the scope of growth of product companies in the global warts therapeutics market?
  • What will be the Y-o-Y growth of the global warts therapeutics market between 2020 and 2030?
  • What is the influence of changing trends in treatment procedures on the global warts therapeutics market?
  • Will North America continue to be the most profitable market for warts therapeutics providers?
  • Which factors are anticipated to hamper the growth of the global warts therapeutics market during the forecast period?
  • Which are the leading companies in the global warts therapeutics market?

Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global warts therapeutics market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary sources referred to by analysts during the production of the global warts therapeutics market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, and market intelligence managers, who contributed to the production of TMR's study on the addiction treatment market as primary research sources.

These primary and secondary research sources have provided exclusive information during interviews, which serves as a validation from the addiction treatment market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global warts therapeutics market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR's estimates on future prospects of the global warts therapeutics market more reliably and accurately.

Table of Contents

Chapter 1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

Chapter 2. Assumptions and Research Methodology

Chapter 3. Executive Summary: Global Warts Therapeutics Market

Chapter 4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Overview
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunity

Chapter 5. Key Insights

  • 5.1. Pipeline Analysis - Warts Therapeutics Market
  • 5.2. Global Warts Therapeutics Market - COVID-19 Impact Analysis
  • 5.3. Global Warts Therapeutics Market ­- Regulatory Scenario

Chapter 6. Global Warts Therapeutics Market Analysis and Forecast, by Warts Type

  • 6.1. Key Findings / Developments
  • 6.2. Introduction & Definition
  • 6.3. Global Warts Therapeutics Market Value Forecast, by Warts Type, 2018-2030
    • 6.3.1. Common Warts
    • 6.3.2. Genital Warts
    • 6.3.3. Flat Warts
    • 6.3.4. Others
  • 6.4. Global Warts Therapeutics Market Attractiveness, by Warts Type

Chapter 7. Global Warts Therapeutics Market Analysis and Forecast, by Treatment Type

  • 7.1. Key Findings / Developments
  • 7.2. Introduction & Definition
  • 7.3. Global Warts Therapeutics Market Value Forecast, by Treatment Type, 2018-2030
    • 7.3.1. Physical Destruction
      • 7.3.1.1. Freezing (Cryotherapy)
        • 7.3.1.1.1. Liquid Nitrogen
        • 7.3.1.1.2. Nitrous Oxide
        • 7.3.1.1.3. Dimethyl Ether and Propane
      • 7.3.1.2. Surgical Removal
      • 7.3.1.3. Laser Treatment
    • 7.3.2. Chemical Destruction
      • 7.3.2.1. Bleomycin
      • 7.3.2.2. Cantharidin
      • 7.3.2.3. Salicylic acid
      • 7.3.2.4. Others
    • 7.3.3. Immunomodulation
      • 7.3.3.1. Interferons
      • 7.3.3.2. Zinc
      • 7.3.3.3. Retinoid
  • 7.4. Global Warts Therapeutics Market Attractiveness, by Treatment Type

Chapter 8. Global Warts Therapeutics Market Analysis and Forecast, by End-user

  • 8.1. Key Findings / Developments
  • 8.2. Introduction & Definition
  • 8.3. Global Warts Therapeutics Market Value Forecast, by End-user, 2018-2030
    • 8.3.1. Hospitals
    • 8.3.2. Clinic
    • 8.3.3. Others
  • 8.4. Global Warts Therapeutics Market Attractiveness, by End-user

Chapter 9. Global Warts Therapeutics Market Analysis and Forecast, by Geography/Region

  • 9.1. Geographical Representation
  • 9.2. Global Warts Therapeutics Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Global Warts Therapeutics Market Attractiveness, by Region

Chapter 10. North America Warts Therapeutics Market Analysis and Forecast

  • 10.1. North America Warts Therapeutics Market Value Forecast, by Country , 2018-2030
    • 10.1.1. U.S.
    • 10.1.2. Canada
  • 10.2. North America Warts Therapeutics Market Value Forecast, by Warts Type, 2018-2030
  • 10.3. North America Warts Therapeutics Market Value Forecast, by Treatment Type, 2018-2030
  • 10.4. North America Warts Therapeutics Market Value Forecast, by End-user, 2018-2030
  • 10.5. North America Warts Therapeutics Market Attractiveness Analysis
    • 10.5.1. By Country
    • 10.5.2. By Warts
    • 10.5.3. By Treatment Type
    • 10.5.4. By End-user

Chapter 11. Europe Warts Therapeutics Market Analysis and Forecast

  • 11.1. Europe Warts Therapeutics Market Value Forecast, by Country/Sub-region, 2018-2030
    • 11.1.1. Germany
    • 11.1.2. France
    • 11.1.3. U.K.
    • 11.1.4. Spain
    • 11.1.5. Italy
    • 11.1.6. Rest of Europe
  • 11.2. Europe Warts Therapeutics Market Value Forecast, by Warts Type, 2018-2030
  • 11.3. Europe Warts Therapeutics Market Value Forecast, by Treatment Type, 2018-2030
  • 11.4. Europe Warts Therapeutics Market Value Forecast, by End-user, 2018-2030
  • 11.5. Europe Warts Therapeutics Market Attractiveness Analysis
    • 11.5.1. By Country/Sub-region
    • 11.5.2. By Warts Type
    • 11.5.3. By Treatment Type
    • 11.5.4. By End-user

Chapter 12. Asia Pacific Warts Therapeutics Market Analysis and Forecast

  • 12.1. Asia Pacific Warts Therapeutics Market Value Forecast, by Country/Sub-region, 2018-2030
    • 12.1.1. Japan
    • 12.1.2. China
    • 12.1.3. India
    • 12.1.4. Australia & New Zealand
    • 12.1.5. Rest of APAC
  • 12.2. Asia Pacific Warts Therapeutics Market Value Forecast, by Warts Type, 2018-2030
  • 12.3. Asia Pacific Warts Therapeutics Market Value Forecast, by Treatment Type, 2018-2030
  • 12.4. Asia Pacific Warts Therapeutics Market Value Forecast, by End-user, 2018-2030
  • 12.5. Asia Pacific Warts Therapeutics Market Attractiveness Analysis
    • 12.5.1. By Country/Sub-region
    • 12.5.2. By Warts Type
    • 12.5.3. By Treatment Center
    • 12.5.4. By End-user

Chapter 13. Latin America Warts Therapeutics Market Analysis and Forecast

  • 13.1. Latin America Warts Therapeutics Market Value Forecast, by Country/Sub-region, 2018-2030
    • 13.1.1. Brazil
    • 13.1.2. Mexico
    • 13.1.3. Rest of Latin America
  • 13.2. Latin America Warts Therapeutics Market Value Forecast, by Warts Type, 2018-2030
  • 13.3. Latin America Warts Therapeutics Market Value Forecast, by Treatment Type, 2018-2030
  • 13.4. Latin America Warts Therapeutics Market Value Forecast, by End-user, 2018-2030
  • 13.5. Latin America Warts Therapeutics Market Attractiveness Analysis
    • 13.5.1. By Country/Sub-region
    • 13.5.2. By Warts Type
    • 13.5.3. By Treatment Center
    • 13.5.4. By End-user

Chapter 14. Middle East & Africa Warts Therapeutics Market Analysis and Forecast

  • 14.1. Middle East & Africa Warts Therapeutics Market Value Forecast, by Country/Sub-region, 2018-2030
    • 14.1.1. GCC Countries
    • 14.1.2. South Africa
    • 14.1.3. Rest of Middle East & Africa
  • 14.2. Middle East & Africa Warts Therapeutics Market Value Forecast, by Warts Type, 2018-2030
  • 14.3. Middle East & Africa Warts Therapeutics Market Value Forecast, by Treatment Type, 2018-2030
  • 14.4. Middle East & Africa Warts Therapeutics Market Value Forecast, by End-user, 2018-2030
  • 14.5. Middle East & Africa Warts Therapeutics Market Attractiveness Analysis
    • 14.5.1. By Country/Sub-region
    • 14.5.2. By Warts Type
    • 14.5.3. By Treatment Center
    • 14.5.4. By End-user

Chapter 15. Competition Landscape

  • 15.1. Competition Matrix
    • 15.1.1. Prestige Consumer Healthcare, Inc.
    • 15.1.2. Bausch Health Companies, Inc.
  • 15.2. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
    • 15.2.1. Prestige Consumer Healthcare, Inc.
      • 15.2.1.1. Company Details
      • 15.2.1.2. Company Description
      • 15.2.1.3. Business Overview
      • 15.2.1.4. SWOT Analysis
      • 15.2.1.5. Financial Analysis
      • 15.2.1.6. Strategic Overview
    • 15.2.2. Bausch Health Companies, Inc.
      • 15.2.2.1. Company Details
      • 15.2.2.2. Company Description
      • 15.2.2.3. Business Overview
      • 15.2.2.4. SWOT Analysis
      • 15.2.2.5. Strategic Overview
    • 15.2.3. Phio Pharmaceuticals Corp.
      • 15.2.3.1. Company Details
      • 15.2.3.2. Company Description
      • 15.2.3.3. Business Overview
      • 15.2.3.4. SWOT Analysis
      • 15.2.3.5. Strategic Overview
    • 15.2.4. Verrica Pharmaceuticals
      • 15.2.4.1. Company Details
      • 15.2.4.2. Company Description
      • 15.2.4.3. Business Overview
      • 15.2.4.4. SWOT Analysis
      • 15.2.4.5. Strategic Overview
    • 15.2.5. Teva Pharmaceuticals Industries Ltd.
      • 15.2.5.1. Company Details
      • 15.2.5.2. Company Description
      • 15.2.5.3. Business Overview
      • 15.2.5.4. SWOT Analysis
      • 15.2.5.5. Financial Analysis
      • 15.2.5.6. Strategic Overview
    • 15.2.6. Mylan N.V.
      • 15.2.6.1. Company Details
      • 15.2.6.2. Company Description
      • 15.2.6.3. Business Overview
      • 15.2.6.4. SWOT Analysis
      • 15.2.6.5. Financial Analysis
      • 15.2.6.6. Strategic Overview
    • 15.2.7. Scholl's Wellness Co.
      • 15.2.7.1. Company Details
      • 15.2.7.2. Company Description
      • 15.2.7.3. Business Overview
      • 15.2.7.4. SWOT Analysis
      • 15.2.7.5. Financial Analysis
      • 15.2.7.6. Strategic Overview
    • 15.2.8. Taro Pharmaceuticals Industries Ltd.
      • 15.2.8.1. Company Details
      • 15.2.8.2. Company Description
      • 15.2.8.3. Business Overview
      • 15.2.8.4. SWOT Analysis
      • 15.2.8.5. Financial Analysis
      • 15.2.8.6. Strategic Overview
    • 15.2.9. Cipla Ltd.
      • 15.2.9.1. Company Details
      • 15.2.9.2. Company Description
      • 15.2.9.3. Business Overview
      • 15.2.9.4. SWOT Analysis
      • 15.2.9.5. Strategic Overview
    • 15.2.10. GlaxoSmithKline plc
      • 15.2.10.1. Company Details
      • 15.2.10.2. Company Description
      • 15.2.10.3. Business Overview
      • 15.2.10.4. SWOT Analysis
      • 15.2.10.5. Strategic Overview
    • 15.2.11. Novan, Inc.
      • 15.2.11.1. Company Details
      • 15.2.11.2. Company Description
      • 15.2.11.3. Business Overview
      • 15.2.11.4. SWOT Analysis
      • 15.2.11.5. Strategic Overview
    • 15.2.12. AIM ImmunoTech, Inc.
      • 15.2.12.1. Company Details
      • 15.2.12.2. Company Description
      • 15.2.12.3. Business Overview
      • 15.2.12.4. SWOT Analysis
      • 15.2.12.5. Strategic Overview
    • 15.2.13. Merck & Co., Inc.
      • 15.2.13.1. Company Details
      • 15.2.13.2. Company Description
      • 15.2.13.3. Business Overview
      • 15.2.13.4. SWOT Analysis
      • 15.2.13.5. Strategic Overview
Back to Top
전화 문의
F A Q